Prescription drug · NDA
Potassium Phosphates (Potassium phosphates in sodium chloride) NDC 70121-1722
Potassium phosphate, Monobasic 4.48 mg/mL; Potassium phosphate, Dibasic 4.72 mg/mL · Injection · Intravenous · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70121-1722-9 | 7012117220970121172209 | 24 POUCH in 1 CARTON (70121-1722-9) / 1 BAG in 1 POUCH / 250 mL in 1 BAGMarketed from Jul 30, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Potassium Phosphates
- Generic name (nonproprietary)
- potassium phosphates in sodium chloride
- Active ingredients
- Potassium phosphate, Monobasic — 4.48 mg/mLPotassium phosphate, Dibasic — 4.72 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Amneal Pharmaceuticals LLCNDC labeler code 70121
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 218343
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 70121-1722_def7f258-3637-4362-b77d-e16904796cd5SPL ID def7f258-3637-4362-b77d-e16904796cd5SPL set ID dce22c93-aa48-48a9-ac8b-716400d33c9eRxCUI 2688947UNII 4J9FJ0HL51, CI71S98N1ZUPC 0370121172291
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470121172209followed by a unit qualifier and the quantityPackage 70121-1722-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Potassium Phosphates in Sodium Chloride Injection is indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient, or contraindicated. Potassium Phosphates in Sodium Chloride Injection is a phosphorus replacement product indicated as a source of phosphorus to correct hypophosphatemia in adults and pediatric patients who weigh 40 kg or greater when oral or enteral replacement is not possible, insufficient or contraindicated. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70121-1722
- What is NDC 70121-1722?
- 70121-1722 is the product NDC for Potassium Phosphates (potassium phosphates in sodium chloride), Potassium phosphate, Monobasic 4.48 mg/mL; Potassium phosphate, Dibasic 4.72 mg/mL injection, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Potassium Phosphates (Potassium Phosphates in sodium chloride).
- What is the active ingredient?
- Potassium phosphate, Monobasic, Potassium phosphate, Dibasic.
- Who is the labeler?
- Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Potassium Phosphates?
- 22 other product NDCs are listed under this name. See all Potassium Phosphates NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Potassium Phosphates products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | 65145-194 | 65145-0194-25 |
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | 65145-195 | 65145-0195-25 |
| Potassium Phosphates | Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Caplin Steriles Limited | 65145-196 | 65145-0196-25 |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-786 | 68462-0786-25 |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-787 | 68462-0787-25 |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-788 | 68462-0788-25 |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | Injection, Solution, ConcentrateIntravenous | Hospira, Inc. | 0409-0032 | 00409-0032-01 |
| Potassium Phosphates | Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-656 | 65219-0656-10 |
| Potassium Phosphates | Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-658 | 65219-0658-25 |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | InjectionIntravenous | Cipla USA Inc. | 69097-055 | 69097-0055-97 |